等待开盘 08-25 09:30:00 美东时间
-0.350
-2.01%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Wedbush analyst Ygal Arounian maintains Criteo (NASDAQ:CRTO) with a Outperform and lowers the price target from $30 to $25.
08-21 00:49
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
Benchmark analyst Mark Zgutowicz maintains Criteo (NASDAQ:CRTO) with a Buy and lowers the price target from $25 to $21.
08-06 22:59
Criteo SA ( ($CRTO) ) has issued an update. On August 5, 2026, Criteo S.A. anno...
08-06 05:28
Criteo (CRTO) shares plunged as much as 26% Wednesday to a six-week low after the digital advertising technology company cut its full-year outlook and issued weaker-than-expected third-quarter guidanc...
08-06 02:03
Criteo shares are trading lower after the company reported Q2 financial results and Q3 Contribution ex-TAC guidance below estimates. Also, the company cut its FY26 Contribution ex-TAC guidance below estimates.
08-05 20:29
Criteo (NASDAQ:CRTO) lowers FY2026 Contribution ex-TAC outlook from $1.175 billion-$1.198 billion to $1.034 billion-$1.058 billion vs $1.140 billion estimate.
08-05 19:07
Criteo (NASDAQ:CRTO) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.71 by 12.68 percent. This is a 13.04 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $428.018 million which be...
08-05 19:02
After Six Years as Chief Financial Officer, Sarah Glickman to Transition to Advisory Role NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Criteo S.A. (NASDAQ: CRTO), ("Criteo" or the "Company"), the ...
08-05 19:00